Chen et al. reported that magnolol enhanced the therapeutic efficacy of regorafenib though the induction of apoptosis by inhibiting myeloid cell leukemia 1 (Mcl-1) and VEGFA expression in hepatocellular carcinoma cells [31]. The gene discussed is MCL1; the disease is hepatocellular carcinoma.